Advantage Trust Company’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-63
Closed -$4.7K 194
2025
Q2
$4.7K Hold
63
﹤0.01% 198
2025
Q1
$5.55K Sell
63
-162
-72% -$15.3K ﹤0.01% 143
2024
Q4
$20.5K Hold
225
0.01% 136
2024
Q3
$25.2K Hold
225
0.02% 121
2024
Q2
$22K Hold
225
0.02% 138
2024
Q1
$22.6K Sell
225
-225
-50% -$19.8K 0.02% 135
2023
Q4
$40.4K Buy
+450
New +$35.9K 0.03% 125

Other funds holding EMN

Advantage Trust Company's EMN Position: Q3 2025 in Review

Advantage Trust Company sold out of Eastman Chemical (EMN) in Q3 2025, closing a stake of 63 shares — an estimated $4.7K sold.

Advantage Trust Company first reported a position in EMN in Q4 2023 and held it in 7 quarters. The position peaked at $40.4K in Q4 2023. 663 funds tracked by Wall St. Rank hold EMN as of Q3 2025.

  • Advantage Trust Company reported no remaining Eastman Chemical position as of Q3 2025 after selling out during the quarter.
  • Advantage Trust Company sold 63 Eastman Chemical shares in Q3 2025, an estimated $4.7K.
  • Advantage Trust Company first reported a position in Eastman Chemical in Q4 2023 and held it in 7 quarters.
  • Advantage Trust Company's Eastman Chemical position peaked at $40.4K in Q4 2023.
  • 663 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2025.

Based on Advantage Trust Company's 13F filing for Q3 2025, filed 3 Nov 2025.